No requirement of perioperative glucocorticoid replacement in patients with endogenous Cushing’s syndrome – a pilot study
Open Access
- 22 April 2024
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 85 (2) , 926-936
Abstract
Purpose: Surgical therapy represents the first-line treatment for endogenous Cushing’s syndrome (CS). While postoperative glucocorticoid replacement is mandatory after surgical remission, the role of perioperative glucocorticoid therapy is unclear. Methods: We recruited patients with central or adrenal CS in whom curative surgery was planned and patients who underwent pituitary surgery for other reasons than CS as a control group. Patients did not receive any perioperative glucocorticoids until the morning of the first postoperative day. We performed blood samplings in the morning of surgery, immediately after surgery, in the evening of the day of surgery, and in the morning of the first and third postoperative day before any morning glucocorticoid intake. We continued clinical and biochemical monitoring during the following outpatient care. Results: We recruited 12 patients with CS (seven with central CS, five with adrenal CS) and six patients without CS. In patients with CS, serum cortisol concentrations 138 nmol/L) after 129 ± 97 days and glucocorticoids were discontinued after 402 ± 243 days. Patients without CS did not require glucocorticoid replacement at any time. Conclusion: Perioperative glucocorticoid replacement may be unnecessary in patients with central or adrenal CS undergoing curative surgery as first-line treatment.Keywords
This publication has 37 references indexed in Scilit:
- Cushing's syndromeThe Lancet, 2023
- Notfallausweis, Notfallmedikation und Informationsmaterial zur Prävention und Therapie der Nebennierenkrise (Addison-Krise): Ein österreichisches KonsensusdokumentJournal für Klinische Endokrinologie und Stoffwechsel, 2022
- Perioperative glucocorticoid supplementation for patients undergoing endoscopic transsphenoidal pituitary tumour surgery: using a sledgehammer to crack a nut?British Journal of Anaesthesia, 2021
- Epidemiology and mortality of Cushing’s syndromeBest Practice & Research Clinical Endocrinology & Metabolism, 2021
- Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndromeEndocrine, 2016
- Complications of Cushing's syndrome: state of the artThe Lancet Diabetes & Endocrinology, 2016
- Cushing's syndromeThe Lancet, 2015
- Surgical management of Cushing’s diseasePituitary, 2015
- Peri-operative management of Cushing’s diseaseReviews in Endocrine and Metabolic Disorders, 2010
- Morning plasma free cortisol: Inability to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing statesJournal of Endocrinological Investigation, 1995